Name: Biotechnology company Regeneron buying 23andMe for $256 million
Channel: TEGNA
Description: Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy.

Kurator

For Seller Marketplace

Request License

> Media Pool

> Biotechnology company Regeneron buying 23andMe for $256 million

Biotechnology company Regeneron buying 23andMe for $256 million

Clip ID 2512226

Clearance

Add to

By Request

By Request assets are not available for immediate purchase.

This content has not been pre-checked for copyright.

Per clip rates are for 20 seconds of final usage. If you are using more then 20 seconds or need a different file format or have questions about clearances contact us

Description

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy.

Station

WUSA

Keywords

national news

Related Footage